Drugs / Dicycloplatin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT05472896 | Jun 2022 → Jun 2024 | hepatocellular carcinoma | Gao-jun Teng | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dicycloplatin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05472896 ↗ |
| Known as | TP21 | “Dicycloplatin (TP21)” NCT05472896 ↗ |